Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients (CeTeG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01149109
Recruitment Status : Completed
First Posted : June 23, 2010
Last Update Posted : June 14, 2017
Sponsor:
Information provided by (Responsible Party):
Ulrich Herrlinger, University Hospital, Bonn

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 6, 2017
Actual Study Completion Date : April 6, 2017
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):